GSP timeline
Every GSP batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| GSP-2605-K3362 | ARA-290 | 11 May 2026 | 2026-Q2 | 5 | 99.45 | 0.58 | 99.90 | +0.45 | |
| GSP-2603-E3156 | Survodutide | 24 Mar 2026 | 2026-Q3 | 8 | 98.32 | 1.99 | 98.79 | +0.47 | |
| GSP-2601-S3404 | Semaglutide | 08 Jan 2026 | 2026-Q2 | 1 | 99.03 | n<2 | 99.24 | +0.21 | |
| GSP-2512-H3291 | Selank | 25 Dec 2025 | 2026-Q1 | 6 | 99.54 | 0.46 | 99.07 | -0.47 | |
| GSP-2512-E2935 | BPC-157 | 15 Dec 2025 | 2026-Q2 | 3 | 99.28 | 0.48 | 99.12 | -0.16 | |
| GSP-2512-N3921 | PT-141 (Bremelanotide) | 03 Dec 2025 | 2026-Q2 | 8 | 99.65 | 0.65 | 99.24 | -0.41 | |
| GSP-2512-H2838 | Semaglutide | 01 Dec 2025 | 2026-Q2 | 7 | 98.40 | 0.90 | 98.40 | 0.00 | |
| GSP-2511-C3427 | SLU-PP-332 | 08 Nov 2025 | 2025-Q4 | 12 | 99.01 | 0.78 | 99.07 | +0.06 | |
| GSP-2511-Y4058 | TB-500 | 02 Nov 2025 | 2026-Q2 | 2 | 99.45 | 0.31 | 99.38 | -0.07 | |
| GSP-2508-F3139 | GHRP-6 | 30 Aug 2025 | 2025-Q3 | 11 | 99.57 | 0.67 | 99.73 | +0.16 | |
| GSP-2508-S3252 | TB-500 | 17 Aug 2025 | 2026-Q1 | 1 | 99.09 | n<2 | 99.23 | +0.14 | |
| GSP-2508-H3518 | BPC-157 | 14 Aug 2025 | 2026-Q1 | 2 | 98.71 | 0.24 | 99.07 | +0.36 | |
| GSP-2508-Y3631 | PT-141 (Bremelanotide) | 10 Aug 2025 | 2025-Q4 | 1 | 99.37 | n<2 | 99.22 | -0.15 | |
| GSP-2508-U3747 | Afamelanotide | 09 Aug 2025 | 2025-Q4 | 1 | 99.55 | n<2 | 99.81 | +0.26 | |
| GSP-2507-A3926 | NAD+ | 15 Jul 2025 | 2025-Q3 | 2 | 99.09 | 0.49 | 99.26 | +0.17 | |
| GSP-2506-P4163 | Liraglutide | 23 Jun 2025 | 2025-Q4 | 1 | 99.10 | n<2 | 99.03 | -0.07 | |
| GSP-2506-D2459 | Oxytocin | 16 Jun 2025 | 2025-Q3 | 1 | 99.23 | n<2 | 99.26 | +0.03 | |
| GSP-2505-S3921 | AOD-9604 | 13 May 2025 | 2025-Q4 | 12 | 98.60 | 0.72 | 98.62 | +0.02 | |
| GSP-2503-B3620 | NAD+ | 20 Mar 2025 | 2025-Q3 | 3 | 99.77 | 0.09 | 99.83 | +0.06 | |
| GSP-2501-G3708 | Tesamorelin | 24 Jan 2025 | 2025-Q1 | 12 | 98.29 | 1.00 | 98.51 | +0.22 | |
| GSP-2501-J2797 | Thymosin α1 | 19 Jan 2025 | 2025-Q2 | 2 | 98.44 | 0.29 | 99.15 | +0.71 | |
| GSP-2501-R2783 | MK-677 (Ibutamoren mesylate) | 18 Jan 2025 | 2025-Q1 | 10 | 99.47 | 1.03 | 100.00 | +0.53 | |
| GSP-2411-B2857 | Retatrutide | 29 Nov 2024 | 2025-Q2 | 16 | 97.83 | 0.97 | 98.25 | +0.42 | |
| GSP-2411-L2462 | AOD-9604 | 10 Nov 2024 | 2025-Q2 | 8 | 98.83 | 0.85 | 99.21 | +0.38 | |
| GSP-2411-J3700 | Vilon | 06 Nov 2024 | 2025-Q1 | 4 | 99.29 | 0.90 | 99.40 | +0.11 | |
| GSP-2410-U4092 | LL-37 | 03 Oct 2024 | 2024-Q4 | 1 | 98.30 | n<2 | 98.04 | -0.26 | |
| GSP-2408-K2819 | Semax | 31 Aug 2024 | 2024-Q4 | 2 | 99.85 | 0.16 | 99.90 | +0.05 | |
| GSP-2405-W3331 | Semaglutide | 08 May 2024 | 2024-Q2 | 15 | 99.01 | 1.18 | 98.12 | -0.89 | |
| GSP-2404-P2784 | Semax | 29 Apr 2024 | 2024-Q3 | 13 | 99.93 | 0.43 | 99.87 | -0.06 | |
| GSP-2402-G3728 | BPC-157 | 14 Feb 2024 | 2024-Q1 | 3 | 99.24 | 0.48 | 98.88 | -0.36 | |
| GSP-2401-W2583 | TB-500 | 12 Jan 2024 | 2024-Q2 | 4 | 98.72 | 0.96 | 99.44 | +0.72 | |
| GSP-2311-C2917 | Hexarelin | 11 Nov 2023 | 2024-Q1 | 3 | 99.01 | 0.23 | 99.45 | +0.44 |